Wordt geladen...
In Reply
Many factors contribute to patient survival in metastatic breast cancer and other late-stage cancers. It is doubtful that adjuvant therapy causes a worse survival outcome. This being said, should resistance develop following adjuvant therapy, the patient needs to be offered a first-line solution tha...
Bewaard in:
Gepubliceerd in: | Oncologist |
---|---|
Hoofdauteurs: | , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
AlphaMed Press
2015
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4294611/ https://ncbi.nlm.nih.gov/pubmed/25589501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0284 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|